高级检索
Inhibition of autophagy augments chemotherapy in human salivary adenoid cystic carcinoma

    作者

    Jiang, LC;Huang, SY;Zhang, DS;Zhang, B;Li, KY;Li, WG;Zhang, SZ;Zhang, WD;Zheng, PH

    作者单位

    [Jiang, Licheng; Huang, Shengyun; Zhang, Dongsheng; Li, Wengang; Zhang, Shizhou; Zhang, Weidong; Zheng, Peihui] Shandong Univ, Dept Oral & Maxillofacial Surg, Prov Hosp, Jinan 250021, Peoples R China.;-;[Zhang, Bin; Li, Keyi] Liaocheng Peoples Hosp, Dept Oral & Maxillofacial Surg, Liaocheng, Peoples R China.

    摘要

    Although cisplatin (DDP)-based adjuvant chemotherapy is widely used in the treatment of salivary adenoid cystic carcinoma (SACC), SACCs have developed resistance to cisplatin, resulting in chemotherapy failure. Autophagy serves as a critical adaptive response, which was increased in tumor cells in chemotherapy. However, the function of autophagy is not clear in SACC. In this study, apoptosis induced by DDP in SACC high metastatic cell line (ACC-M) was revealed using MTT assay, flow cytometry, and caspase-3 immunoblotting. The autophagy activation induced by DDP treatment was measured by transmission electron microscopy, green fluorescent protein-light chain 3 plasmid transfection LC3 immunoblotting and p62 immunoblotting. 3-methyladenine (3-MA) or small interference RNA targeting beclin 1 (beclin 1 siRNA) inhibited autophagy and significantly enhanced DDP-induced apoptosis. ACC-M xenografts in nude mice further verified the synergistic effect of DDP and 3-MA. In conclusion, autophagy activation was caused to protect cancer cells from DDP-induced apoptosis and autophagy inhibition could be a promising strategy for adjuvant chemotherapy in SACC.

    关键词

    HUMAN CANCER-CELLS; INDUCED APOPTOSIS; GROWTH-CONTROL; P53; THERAPY; DEATH; PATHWAYS; SUPPRESSION; MECHANISMS; STRESS
基本信息

  • 所属机构:

    归属医师: 张东升 张卫东 张世周 李文刚 郑培惠 黄圣运

    PMID:24118359

    UT:000333746900005

    刊名:JOURNAL OF ORAL PATHOLOGY & MEDICINE

    年,卷(期):2014年43卷4期

    页码:265-272

    DOI:10.1111/jop.12124

    附件:

    收录:   SCIE